Effects of hypokalemia and disopyramide on electrical induction of ventricular tachyarrhythmia in nonischemic heart

Katsusuke Yano, Kakota Gaston Kapuku, Tetsuya Hirata, Motonobu Hayano

Research output: Contribution to journalArticle

Abstract

This study examined the relationship between hypokalemia and ventricular tachyarrhythmia in nonischemic heart, and tried to determine whether hypokalemia enhances the proarrhythmic effect of ventricular repolarization-prolonging drugs. In 12 mongrel dogs (group 1), hypokalemia was produced by infusion of 5.0 g/kg of polystyrene sulfonic acid calcium into the colon while 8 other dogs (group 2) were maintained normokalemic. Programmed ventricular stimulation (PVS) was performed in the two groups before and after injection of disopyramide (i.v., 2.0 mg/kg). In group 1, serum potassium decreased from 4.1 ± 0.3 to 2.7 ± 0.4 mEq/L. QRS duration increased from 49 ± 2 to 60 ± 3 msec (p < 0.01). Effective refractory period (ERP) increased (p < 0.01). Monophasic action potential at 90% (MAP90) lengthened by 10% (not significant). Disopyramide significantly increased the above parameters, as well as the slope of the linear relation between percentage changes of MAP90 and potassium. Before production of hypokalemia, none out of 12 dogs (group 1) developed ventricular tachyarrhythmia in response to PVS. Five (42%) our of 12 hypokalemic dogs showed positive responses to PVS (four ventricular fibrillation, one nonsustained ventricular tachycardia). After administration of disopyramide, 7 (57%) out of 12 hypokalemic dogs showed positive responses to PVS (three ventricular fibrillation, four nonsustained ventricular tachycardia). In normokalemic dogs (group 2), no ventricular tachyarrhythmia could be induced before administration of disopyramide. After disopyramide administration, two (25%) out of eight normokalemic dogs developed ventricular fibrillation in response to PVS. Thus, hypokalemia is predictive of ventricular tachyarrhythmia even in nonischemic heart. Moreover, disopyramide-related prolongation of ventricular repolarization time can be a condition for proarrhythmic effect in a nonischemic heart in the presence of hypokalemia.

Original languageEnglish (US)
Pages (from-to)105-109
Number of pages5
JournalInternational Journal of Angiology
Volume5
Issue number2
DOIs
StatePublished - May 8 1996

Fingerprint

Disopyramide
Hypokalemia
Tachycardia
Dogs
Ventricular Fibrillation
Ventricular Tachycardia
Action Potentials
Potassium
Colon
Calcium
Injections
Serum

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Effects of hypokalemia and disopyramide on electrical induction of ventricular tachyarrhythmia in nonischemic heart. / Yano, Katsusuke; Kapuku, Kakota Gaston; Hirata, Tetsuya; Hayano, Motonobu.

In: International Journal of Angiology, Vol. 5, No. 2, 08.05.1996, p. 105-109.

Research output: Contribution to journalArticle

@article{48df744a185948a88ef35e095a77f965,
title = "Effects of hypokalemia and disopyramide on electrical induction of ventricular tachyarrhythmia in nonischemic heart",
abstract = "This study examined the relationship between hypokalemia and ventricular tachyarrhythmia in nonischemic heart, and tried to determine whether hypokalemia enhances the proarrhythmic effect of ventricular repolarization-prolonging drugs. In 12 mongrel dogs (group 1), hypokalemia was produced by infusion of 5.0 g/kg of polystyrene sulfonic acid calcium into the colon while 8 other dogs (group 2) were maintained normokalemic. Programmed ventricular stimulation (PVS) was performed in the two groups before and after injection of disopyramide (i.v., 2.0 mg/kg). In group 1, serum potassium decreased from 4.1 ± 0.3 to 2.7 ± 0.4 mEq/L. QRS duration increased from 49 ± 2 to 60 ± 3 msec (p < 0.01). Effective refractory period (ERP) increased (p < 0.01). Monophasic action potential at 90{\%} (MAP90) lengthened by 10{\%} (not significant). Disopyramide significantly increased the above parameters, as well as the slope of the linear relation between percentage changes of MAP90 and potassium. Before production of hypokalemia, none out of 12 dogs (group 1) developed ventricular tachyarrhythmia in response to PVS. Five (42{\%}) our of 12 hypokalemic dogs showed positive responses to PVS (four ventricular fibrillation, one nonsustained ventricular tachycardia). After administration of disopyramide, 7 (57{\%}) out of 12 hypokalemic dogs showed positive responses to PVS (three ventricular fibrillation, four nonsustained ventricular tachycardia). In normokalemic dogs (group 2), no ventricular tachyarrhythmia could be induced before administration of disopyramide. After disopyramide administration, two (25{\%}) out of eight normokalemic dogs developed ventricular fibrillation in response to PVS. Thus, hypokalemia is predictive of ventricular tachyarrhythmia even in nonischemic heart. Moreover, disopyramide-related prolongation of ventricular repolarization time can be a condition for proarrhythmic effect in a nonischemic heart in the presence of hypokalemia.",
author = "Katsusuke Yano and Kapuku, {Kakota Gaston} and Tetsuya Hirata and Motonobu Hayano",
year = "1996",
month = "5",
day = "8",
doi = "10.1007/BF02043650",
language = "English (US)",
volume = "5",
pages = "105--109",
journal = "International Journal of Angiology",
issn = "1061-1711",
publisher = "Thieme Medical Publishers",
number = "2",

}

TY - JOUR

T1 - Effects of hypokalemia and disopyramide on electrical induction of ventricular tachyarrhythmia in nonischemic heart

AU - Yano, Katsusuke

AU - Kapuku, Kakota Gaston

AU - Hirata, Tetsuya

AU - Hayano, Motonobu

PY - 1996/5/8

Y1 - 1996/5/8

N2 - This study examined the relationship between hypokalemia and ventricular tachyarrhythmia in nonischemic heart, and tried to determine whether hypokalemia enhances the proarrhythmic effect of ventricular repolarization-prolonging drugs. In 12 mongrel dogs (group 1), hypokalemia was produced by infusion of 5.0 g/kg of polystyrene sulfonic acid calcium into the colon while 8 other dogs (group 2) were maintained normokalemic. Programmed ventricular stimulation (PVS) was performed in the two groups before and after injection of disopyramide (i.v., 2.0 mg/kg). In group 1, serum potassium decreased from 4.1 ± 0.3 to 2.7 ± 0.4 mEq/L. QRS duration increased from 49 ± 2 to 60 ± 3 msec (p < 0.01). Effective refractory period (ERP) increased (p < 0.01). Monophasic action potential at 90% (MAP90) lengthened by 10% (not significant). Disopyramide significantly increased the above parameters, as well as the slope of the linear relation between percentage changes of MAP90 and potassium. Before production of hypokalemia, none out of 12 dogs (group 1) developed ventricular tachyarrhythmia in response to PVS. Five (42%) our of 12 hypokalemic dogs showed positive responses to PVS (four ventricular fibrillation, one nonsustained ventricular tachycardia). After administration of disopyramide, 7 (57%) out of 12 hypokalemic dogs showed positive responses to PVS (three ventricular fibrillation, four nonsustained ventricular tachycardia). In normokalemic dogs (group 2), no ventricular tachyarrhythmia could be induced before administration of disopyramide. After disopyramide administration, two (25%) out of eight normokalemic dogs developed ventricular fibrillation in response to PVS. Thus, hypokalemia is predictive of ventricular tachyarrhythmia even in nonischemic heart. Moreover, disopyramide-related prolongation of ventricular repolarization time can be a condition for proarrhythmic effect in a nonischemic heart in the presence of hypokalemia.

AB - This study examined the relationship between hypokalemia and ventricular tachyarrhythmia in nonischemic heart, and tried to determine whether hypokalemia enhances the proarrhythmic effect of ventricular repolarization-prolonging drugs. In 12 mongrel dogs (group 1), hypokalemia was produced by infusion of 5.0 g/kg of polystyrene sulfonic acid calcium into the colon while 8 other dogs (group 2) were maintained normokalemic. Programmed ventricular stimulation (PVS) was performed in the two groups before and after injection of disopyramide (i.v., 2.0 mg/kg). In group 1, serum potassium decreased from 4.1 ± 0.3 to 2.7 ± 0.4 mEq/L. QRS duration increased from 49 ± 2 to 60 ± 3 msec (p < 0.01). Effective refractory period (ERP) increased (p < 0.01). Monophasic action potential at 90% (MAP90) lengthened by 10% (not significant). Disopyramide significantly increased the above parameters, as well as the slope of the linear relation between percentage changes of MAP90 and potassium. Before production of hypokalemia, none out of 12 dogs (group 1) developed ventricular tachyarrhythmia in response to PVS. Five (42%) our of 12 hypokalemic dogs showed positive responses to PVS (four ventricular fibrillation, one nonsustained ventricular tachycardia). After administration of disopyramide, 7 (57%) out of 12 hypokalemic dogs showed positive responses to PVS (three ventricular fibrillation, four nonsustained ventricular tachycardia). In normokalemic dogs (group 2), no ventricular tachyarrhythmia could be induced before administration of disopyramide. After disopyramide administration, two (25%) out of eight normokalemic dogs developed ventricular fibrillation in response to PVS. Thus, hypokalemia is predictive of ventricular tachyarrhythmia even in nonischemic heart. Moreover, disopyramide-related prolongation of ventricular repolarization time can be a condition for proarrhythmic effect in a nonischemic heart in the presence of hypokalemia.

UR - http://www.scopus.com/inward/record.url?scp=0029879512&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029879512&partnerID=8YFLogxK

U2 - 10.1007/BF02043650

DO - 10.1007/BF02043650

M3 - Article

VL - 5

SP - 105

EP - 109

JO - International Journal of Angiology

JF - International Journal of Angiology

SN - 1061-1711

IS - 2

ER -